Latest Conference Coverage
Male gender, diabetes, and renal function decline at 90 days implicated as risk factors; patients rarely progress to end-stage renal disease.
CKD patients with daily sodium above 4,548 mg may help protect their cardiovascular health by reducing sodium in their diets, researchers suggested.
Japanese study demonstrates a 2-fold increased risk of death from any cause.
As elderly patients age, the number of drugs they take that may cause hyperkalemia increases.
Odds of non-fatal stroke are 49% higher in patients in the fourth quartile of uric acid level versus those in the second quartile.
No new safety concerns observed in a 52-week extension trial of etelcalcetide in hemodialysis with secondary hyperparathyroidism.
Phosphorus levels are higher when blood specimens are collected after weekends.
Paricalcitol-based protocol includes limited use of calcium-based phosphate binders.
Study demonstrates improved 90-day survival and greater likelihood of recovering renal function.
Researchers observe an 81% increase in dialysis patients achieving recommended phosphorus levels after switching to sucroferric oxyhydroxide.
Study also identifies clinical characteristics associated with testosterone deficiency in this population.
Researchers report successful use of catheters within 24 hours in urgent situations.
The condition is independently associated with a 60% increased risk of 5-year mortality in maintenance hemodialysis patients.
Trend started around the introduction of the Medicare prospective payment system for dialysis care.
African-American children are 64% more likely to die than white children.
Regular use of non-steroidal anti-inflammatory drugs for 10 years or more increased the risk of dying from renal cell carcinoma nearly 4-fold.
The protective effect was not observed with other anti-diabetic medications.
Patients who underwent upfront cytoreductive nephrectomy lived 6.4 months longer than those treated with upfront targeted therapy, a study found.
Through diet and exercise, prostate cancer patients can decrease their risk of dying from their illness.
The finding of lower bladder cancer incidence in patients receiving pelvic radiation contrasts with previous research.
Researchers estimate that 40% of pathologic response in MIBC patients receiving both neoadjuvant chemo and TURBT is due to TURBT.
A travel distance of more than 30 miles to the provider was associated with greater chances of readmission in one analysis.
Non-users of 5-alpha-reductase inhibitors had a nearly 2.6 times increased risk of pathologic progression than those who took the drugs.
Patients with higher heterogeneity score did not respond well to hormone therapy.
Second round of 6 injections was well tolerated and continued to control disease progression in bone.
A 50% or greater PSA decline at 15 days after start of treatment was associated with increased progression-free and overall survival.
Researchers observed a trend toward longer time on drug among men with castration-resistant prostate cancer.
The drug nearly doubled the delay in tumor growth compared with everolimus.
In large observational study, regular use—defined as 3 tablets per week—was associated with a 24% lower risk of dying from prostate cancer.
In a small study, high-dose testosterone given intermittently with androgen deprivation therapy lowered PSA levels without serious adverse effects.
- CKD Progression After Acute Kidney Injury Characterized
- High Sodium Intake May Up CVD Risk in CKD Patients
- Guidelines Recommend Weight-loss Surgery to Treat Type 2 Diabetes
- Achieving 4 Lifestyle Standards May Reduce Cancer Mortality
- Fluid Overload at RRT Initiation Ups AKI Patients' Long-Term Mortality
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)